ICD Tachycardia Discrimination via Morphology Feedback
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable cardioverter defibrillators (ICDs) face challenges in accurately discriminating between ventricular tachycardia and fibrillation to deliver appropriate therapies while conserving battery life and minimizing unnecessary shock therapies.
Innovation Solution
The development of a method and apparatus that utilizes a combination of interval-based detection and morphology analysis to differentiate between ventricular tachycardia and fibrillation, incorporating ECG signal processing and supplemental sensors to optimize therapy delivery and reduce unnecessary interventions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If ICD delivers therapy for every detected tachycardia event, then the sensitivity of arrhythmia detection is improved, but the battery charge is depleted faster and the patient receives unnecessary therapies
Solution Approach 1:
The system uses morphology feedback by comparing the shape and characteristics of detected cardiac signals against stored templates to verify true tachycardia events. This feedback mechanism allows the device to distinguish between genuine arrhythmias and false detections, enabling selective therapy delivery that conserves battery while maintaining high sensitivity for actual events
Solution Approach 2:
The system changes detection parameters dynamically by switching between rate-based detection and morphology-based discrimination. When morphology analysis confirms a true tachycardia, therapy is delivered; when morphology indicates a false detection, therapy is withheld. This parameter switching resolves the contradiction by adapting the detection strategy to the specific characteristics of each detected event
2Reliability
If ICD delivers higher voltage therapy, then the effectiveness of arrhythmia termination is improved, but the battery charge is depleted faster
Solution Approach 1:
The system applies partial action by delivering morphology-confirmed therapies only when truly needed, rather than excessive high-voltage shocks for every detected event. By using morphology discrimination to filter detections, the device delivers the full therapeutic effect only for confirmed tachycardias, reducing unnecessary high-energy deliveries while maintaining effectiveness for genuine events
Solution Approach 2:
Morphology analysis provides feedback on the真实性 of each detected tachycardia before therapy delivery. This feedback loop ensures that high-voltage therapies are reserved for confirmed malignant arrhythmias, optimizing the balance between termination effectiveness and energy conservation by avoiding unnecessary high-energy deliveries
3Reliability
If ICD delivers shock therapy, then the arrhythmia termination is achieved, but the patient experiences pain and potential complications
Solution Approach 1:
The system uses morphology feedback to verify true tachycardia before allowing shock delivery. This discrimination capability reduces false-positive therapies, thereby minimizing patient exposure to painful and potentially harmful shocks while maintaining reliable termination for genuine malignant arrhythmias
Solution Approach 2:
The system applies partial action by withholding therapy for suspected false detections and delivering it only for morphology-confirmed tachycardias. This selective approach reduces the total number of shock deliveries to the minimum necessary for effective arrhythmia termination, thereby reducing patient pain and complications
4Measurement precision
If ICD uses morphology discrimination, then the specificity of tachycardia detection is improved, but the device complexity increases
Solution Approach 1:
The detection system is segmented into separate functional modules: rate-based detection module, morphology analysis module, and therapy delivery module. This segmentation allows the complex morphology discrimination function to be implemented as a distinct processing stage that enhances specificity without overwhelming the overall device architecture, making the complexity more manageable and maintainable
Data Source
AI summary
A method and medical device for detecting a cardiac event that includes sensing cardiac signals from a plurality of electrodes, the plurality of electrodes forming a first sensing vector and a second sensing vector, determining, in response to the cardiac event being identified as a shockable event, a first R-wave morphology corresponding to R-waves of a next interval subsequently sensed along the first sensing vector during the predetermined sensing window and a second R-wave morphology corresponding to R-waves of a next interval subsequently sensed along the second sensing vector, determining whether the next interval subsequently sensed along the first sensing vector and the next interval subsequently sensed along the second sensing vector satisfy a morphology metric, and identifying the cardiac event as one of a monomorphic ventricular tachycardia and a polymorphic ventricular tachycardia in response to the determined first R-wave morphology, second R-wave morphology, and the next interval subsequently sensed along the first sensing vector and the next interval subsequently sensed along the second sensing vector not satisfying the morphology metric.